{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:29:17Z","timestamp":1787671757060,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00210-026-05447-x","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:27:18Z","timestamp":1778905638000},"page":"17061-17070","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world clinical validation study: individualized warfarin dosing strategy integrating genetic polymorphisms and Bayesian"],"prefix":"10.1007","volume":"399","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5757-5786","authenticated-orcid":false,"given":"Pu","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunfa","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peitao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"issue":"Database issue","key":"5447_CR1","doi-asserted-by":"publisher","first-page":"D36","DOI":"10.1093\/nar\/gks1195","volume":"41","author":"DA Benson","year":"2013","unstructured":"Benson DA, Cavanaugh M, Clark K, Karsch-Mizrachi I, Lipman DJ, Ostell J, Sayers EW (2013) GenBank. Nucleic Acids Res 41(Database issue):D36\u2013D42. https:\/\/doi.org\/10.1093\/nar\/gks1195","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"5447_CR2","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1007\/s11096-018-0674-0","volume":"40","author":"H Cao","year":"2018","unstructured":"Cao H, Wu J, Zhang J (2018) Outcomes of warfarin therapy managed by pharmacists via hospital anticoagulation clinic versus online anticoagulation clinic. Int J Clin Pharm 40(5):1072\u20131077. https:\/\/doi.org\/10.1007\/s11096-018-0674-0","journal-title":"Int J Clin Pharm"},{"issue":"12","key":"5447_CR3","first-page":"1434","volume":"20","author":"T Dan","year":"2015","unstructured":"Dan T, Han Y, Zhi-Ying L et al (2015) Research progress of establishing the gene-guided dosing predictive model of warfarin [J]. Chin J Clin Pharmacol Ther 20(12):1434\u20131440","journal-title":"Chin J Clin Pharmacol Ther"},{"key":"5447_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002894.pub3","volume":"11","author":"F Gillaizeau","year":"2013","unstructured":"Gillaizeau F, Chan E, Trinquart L, Colombet I, Walton RT, R\u00e8ge-Walther M, Burnand B, Durieux P (2013) Computerized advice on drug dosage to improve prescribing practice. Cochrane Database Syst Rev 11:CD002894. https:\/\/doi.org\/10.1002\/14651858.CD002894.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"5447_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-014-0128-0","volume":"15","author":"AK Hamberg","year":"2015","unstructured":"Hamberg AK, Hellman J, Dahlberg J, Jonsson EN, Wadelius M (2015) A Bayesian decision support tool for efficient dose individualization of warfarin in adults and children. BMC Med Inform Decis Mak 15:7. https:\/\/doi.org\/10.1186\/s12911-014-0128-0","journal-title":"BMC Med Inform Decis Mak"},{"issue":"3","key":"5447_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/cpt.668","volume":"102","author":"JA Johnson","year":"2017","unstructured":"Johnson JA, Caudle KE, Gong L, Whirl-Carrillo M, Stein CM, Scott SA, Lee MT, Gage BF, Kimmel SE, Perera MA, Anderson JL, Pirmohamed M, Klein TE, Limdi NA, Cavallari LH, Wadelius M (2017) Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for pharmacogenetics-guided warfarin dosing: 2017 update. Clin Pharmacol Ther 102(3):397\u2013404. https:\/\/doi.org\/10.1002\/cpt.668","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"5447_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","volume":"149","author":"C Kearon","year":"2016","unstructured":"Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JRE, Wells P, Woller SC, Moores L (2016) Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 149(2):315\u2013352. https:\/\/doi.org\/10.1016\/j.chest.2015.11.026","journal-title":"Chest"},{"issue":"Suppl 1","key":"5447_CR8","doi-asserted-by":"publisher","first-page":"S266","DOI":"10.1111\/jth.12978","volume":"13","author":"SE Kimmel","year":"2015","unstructured":"Kimmel SE (2015) Warfarin pharmacogenomics: current best evidence. J Thromb Haemost 13(Suppl 1):S266\u2013S271. https:\/\/doi.org\/10.1111\/jth.12978","journal-title":"J Thromb Haemost"},{"issue":"1","key":"5447_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.15420\/cfr.2018:2:2","volume":"4","author":"T Koenig","year":"2018","unstructured":"Koenig T, Bauersachs J, Hilfiker-Kleiner D (2018) Bromocriptine for the treatment of peripartum cardiomyopathy. Card Fail Rev 4(1):46\u201349. https:\/\/doi.org\/10.15420\/cfr.2018:2:2","journal-title":"Card Fail Rev"},{"issue":"11","key":"5447_CR10","first-page":"1299","volume":"19","author":"L Mei-Qin","year":"2014","unstructured":"Mei-Qin L, Jing Z, Liang-Ping YU et al (2014) Advances of individualized administration model of warfarin based on pharmacogenomics [J]. Chin J Clin Pharmacol Ther 19(11):1299\u20131305","journal-title":"Chin J Clin Pharmacol Ther"},{"issue":"4","key":"5447_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/cpt.334","volume":"99","author":"DR Mould","year":"2016","unstructured":"Mould DR, D\u2019Haens G, Upton RN (2016) Clinical decision support tools: the evolution of a revolution. Clin Pharmacol Ther 99(4):405\u2013418. https:\/\/doi.org\/10.1002\/cpt.334","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"5447_CR12","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1208\/s12248-014-9632-5","volume":"16","author":"DR Mould","year":"2014","unstructured":"Mould DR, Upton RN, Wojciechowski J (2014) Dashboard systems: implementing pharmacometrics from bench to bedside. AAPS J 16(5):925\u2013937. https:\/\/doi.org\/10.1208\/s12248-014-9632-5","journal-title":"AAPS J"},{"issue":"3","key":"5447_CR13","first-page":"247","volume":"21","author":"T Pellagatti","year":"2017","unstructured":"Pellagatti T, Ternelli M, Frascio D, Bettini R (2017) Warfarin personalized dosage: re-compounding for a more suitable therapy and better compliance. Int J Pharm Compd 21(3):247\u2013250","journal-title":"Int J Pharm Compd"},{"key":"5447_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01550","volume":"10","author":"A Roche-Lima","year":"2020","unstructured":"Roche-Lima A, Roman-Santiago A, Feliu-Maldonado R, Rodriguez-Maldonado J, Nieves-Rodriguez BG, Carrasquillo-Carrion K, Ramos CM, da Luz Sant\u2019Ana I, Massey SE, Duconge J (2020) Machine learning algorithm for predicting warfarin dose in Caribbean Hispanics using pharmacogenetic data. Front Pharmacol 10:1550. https:\/\/doi.org\/10.3389\/fphar.2019.01550","journal-title":"Front Pharmacol"},{"issue":"2","key":"5447_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/sj.tpj.6500417","volume":"7","author":"M Wadelius","year":"2007","unstructured":"Wadelius M, Pirmohamed M (2007) Pharmacogenetics of warfarin: current status and future challenges. Pharmacogenomics J 7(2):99\u2013111. https:\/\/doi.org\/10.1038\/sj.tpj.6500417","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"5447_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s40262-012-0017-6","volume":"52","author":"DF Wright","year":"2013","unstructured":"Wright DF, Duffull SB (2013) A Bayesian dose-individualization method for warfarin. Clin Pharmacokinet 52(1):59\u201368. https:\/\/doi.org\/10.1007\/s40262-012-0017-6","journal-title":"Clin Pharmacokinet"},{"key":"5447_CR17","unstructured":"Zhang JH, Peng WX, Dong J, Liu XQ, Jiao Z\u00a0(2018) Individualized medication of warfarin by quantitative pharmacology. Chin Pharma J\u00a053(19):1703\u20131708.\u00a0https:\/\/doi.org\/10.11669\/cpj.2018.19.016"},{"issue":"11","key":"5447_CR18","first-page":"1201","volume":"27","author":"J Zhang","year":"2022","unstructured":"Zhang J, Liu M, Cai M et al (2022) Model informed precision dosing of warfarin: China expert consensus report (2022 version) [J]. Chin J Clin Pharmacol Ther 27(11):1201","journal-title":"Chin J Clin Pharmacol Ther"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05447-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05447-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05447-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:57:21Z","timestamp":1787669841000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05447-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5447"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05447-x","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"12 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in accordance with the principles stated in the declaration of Helsinki. This study was approved by the ethics committee of Ordos Central Hospital.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patient provided informed consent for publication of the case. We have obtained the consent of the institution (Ordos Central Hospital) to publish the case details.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study is not a clinical trial.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}